Nozomi Ebata
About
Nozomi Ebata is a scholar working on Pharmacology, Rheumatology and Physiology.
According to data from OpenAlex, Nozomi Ebata has authored 24 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 6 papers in Rheumatology and 6 papers in Physiology. Recurrent topics in Nozomi Ebata's work include Musculoskeletal pain and rehabilitation (9 papers), Inflammatory mediators and NSAID effects (8 papers) and Pain Mechanisms and Treatments (6 papers). Nozomi Ebata is often cited by papers focused on Musculoskeletal pain and rehabilitation (9 papers), Inflammatory mediators and NSAID effects (8 papers) and Pain Mechanisms and Treatments (6 papers). Nozomi Ebata collaborates with scholars based in Japan, United States and United Kingdom. Nozomi Ebata's co-authors include Koichi Fujii, Marco DiBonaventura, Alesia Sadosky, Toshihiko Taguchi, Joseph C. Cappelleri, Kanae Togo, Lucy Abraham, Takahiro Ushida, Tomoyuki Takura and Tsukasa Kanchiku and has published in prestigious journals such as PLoS ONE, BMC Musculoskeletal Disorders and Pain Medicine.
In The Last Decade
Nozomi Ebata
22 papers receiving 310 citations
Peers
Nozomi Ebata
Salah N. El-Tallawy Saudi Arabia
Robert B. Browning United States
Anita Paperini Italy
Sanjog Pangarkar United States
Aline Albi France
Afitap İçağasıoğlu Türkiye
Magdalena Anițescu United States
Tatsuya Hirase Japan
Ian M. Fowler United States
Rachel Goldgrub Canada
Citations per year, relative to Nozomi Ebata Nozomi Ebata (= 1×)
peers
Salah N. El-Tallawy
Countries citing papers authored by Nozomi Ebata
Since
Specialization
Citations
This map shows the geographic impact of Nozomi Ebata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nozomi Ebata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nozomi Ebata more than expected).
Fields of papers citing papers by Nozomi Ebata
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Nozomi Ebata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nozomi Ebata. The network helps show where Nozomi Ebata may publish in the future.
Co-authorship network of co-authors of Nozomi Ebata
This figure shows the co-authorship network connecting the top 25 collaborators of Nozomi Ebata. A scholar is included among the top collaborators of Nozomi Ebata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nozomi Ebata. Nozomi Ebata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Horikawa, Reiko, Toshiaki Tanaka, Yukihiro Hasegawa, et al.. (2025). Efficacy and safety of once-weekly somatrogon following up to 4 years of treatment in Japanese children with growth hormone deficiency: results from an open-label extension of a phase 3 study. Endocrine Journal. 73(1). 21–32.
2.
Akazawa, Manabu, et al.. (2024). Factors Related to Treatment Non-Adherence Among Caregivers of Pediatric and Adolescent Growth Hormone Deficiency Patients in Japan. Patient Preference and Adherence. Volume 18. 607–622.
3.
Ebata, Nozomi, et al.. (2023). Use of analgesics before and after total joint replacement in working-age Japanese patients with knee and hip osteoarthritis: A retrospective database study. Asia-Pacific Journal of Sports Medicine Arthroscopy Rehabilitation and Technology. 35. 1–8.
4.
Ebata, Nozomi, et al.. (2023). Perioperative Analgesics and Anesthesia as Risk Factors for Postoperative Chronic Opioid Use in Patients Undergoing Total Knee Arthroplasty: A Retrospective Cohort Study Using Japanese Hospital Claims Data. Drugs - Real World Outcomes. 10(2). 331–340.
5.
Miki, Kenji, Makoto Ohta, Manabu Abe, et al.. (2022). Efficacy, General Safety, and Joint Safety of Tanezumab in Japanese Patients with Osteoarthritis: Subgroup Analyses from Two Randomized, Phase 3 Studies. Pain and Therapy. 11(3). 827–844.
6.
Fukui, Naoya, Philip G. Conaghan, Kanae Togo, et al.. (2022). Physician and patient perceptions of surgical procedures for osteoarthritis of the knee in the United States, Europe, and Japan: results of a real-world study. BMC Musculoskeletal Disorders. 23(1). 1065–1065.
7.
Kikuchi, Shogo, Kanae Togo, Nozomi Ebata, et al.. (2021). Database Analysis on the Relationships Between Nonsteroidal Anti-inflammatory Drug Treatment Variables and Incidence of Acute Myocardial Infarction in Japanese Patients with Osteoarthritis and Chronic Low Back Pain. Advances in Therapy. 38(3). 1601–1613.
8.
Katsuno, Takayuki, Kanae Togo, Nozomi Ebata, et al.. (2021). Burden of Renal Events Associated with Nonsteroidal Anti-inflammatory Drugs in Patients with Osteoarthritis and Chronic Low Back Pain: A Retrospective Database Study. Pain and Therapy. 10(1). 443–455.
9.
Takura, Tomoyuki, Akira Yuasa, Naohiro Yonemoto, et al.. (2021). Cost-Effectiveness Analysis of the Treatment Strategies with or without Opioid Medications in Surgery-Eligible Patients with Osteoarthritis in Japan. PharmacoEconomics - Open. 6(1). 33–45.
10.
Ebata, Nozomi, et al.. (2020). Treatment and Healthcare Cost Among Patients with Hip or Knee Osteoarthritis: A Cross-sectional Study Using a Real-world Claims Database in Japan Between 2013 and 2019. Clinical Drug Investigation. 40(11). 1071–1084.
11.
Akazawa, Manabu, Kanae Togo, Nozomi Ebata, et al.. (2019). <p>Patterns of drug treatment in patients with osteoarthritis and chronic low back pain in Japan: a retrospective database study</p>. Journal of Pain Research. Volume 12. 1631–1648.
12.
Taguchi, Toshihiko, Bruce Parsons, Tamotsu Yoshiyama, et al.. (2019). <p>Effectiveness of pregabalin for treatment of chronic cervical radiculopathy with upper limb radiating pain: an 8-week, multicenter prospective observational study in Japanese primary care settings</p>. Journal of Pain Research. Volume 12. 1411–1424.
13.
Akazawa, Manabu, Ataru Igarashi, Nozomi Ebata, et al.. (2019). <p>A Cost-Effectiveness Analysis Of Pregabalin For The Treatment Of Patients With Chronic Cervical Pain With A Neuropathic Component In Japan</p>. Journal of Pain Research. Volume 12. 2785–2797.
14.
Ebata, Nozomi, et al.. (2017). Clinical and economic burdens experienced by patients with painful diabetic peripheral neuropathy: An observational study using a Japanese claims database. PLoS ONE. 12(10). e0187250–e0187250.
15.
Lee, Lulu K., Nozomi Ebata, Patrick Hlavacek, et al.. (2016). Humanistic and economic burden of fibromyalgia in Japan. Journal of Pain Research. Volume 9. 967–978.
16.
Takura, Tomoyuki, Takahiro Ushida, Tsukasa Kanchiku, et al.. (2015). The societal burden of chronic pain in Japan: an internet survey. Journal of Orthopaedic Science. 20(4). 750–760.
17.
Sadosky, Alesia, Toshihiko Taguchi, Ataru Igarashi, et al.. (2015). Effectiveness of pregabalin for the treatment of chronic low back pain with accompanying lower limb pain (neuropathic component): a non-interventional study in Japan. Journal of Pain Research. 8. 487–487.
18.
DiBonaventura, Marco, Alesia Sadosky, Joseph C. Cappelleri, Nozomi Ebata, & Koichi Fujii. (2015). The association between lower back pain and health status, work productivity, and health care resource use in Japan. Journal of Pain Research. 8. 119–119.
19.
Sadosky, Alesia, Ataru Igarashi, Manabu Akazawa, et al.. (2015). Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan. ClinicoEconomics and Outcomes Research. 7. 505–505.
20.
Cui, Longzhu, Nozomi Ebata, Yukiko Watanabe, et al.. (2012). THE MUTATION OF <i>rpoB</i> GENE ENCODING BETA-SUBUNIT OF RNA POLYMERASE IS ASSOCIATED WITH IMPROVEMENT OF LINEZOLID SUSCEPTIBILITY IN <i>Staphylococcus aureus</i>. Juntendō Igaku. 58(6). 498–505.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Salah N. El-Tallawy Breakdown of academic impact, for papers by Robert B. Browning Breakdown of academic impact, for papers by Anita Paperini Breakdown of academic impact, for papers by Sanjog Pangarkar Breakdown of academic impact, for papers by Aline Albi Breakdown of academic impact, for papers by Afitap İçağasıoğlu Breakdown of academic impact, for papers by Magdalena Anițescu Breakdown of academic impact, for papers by Tatsuya Hirase Breakdown of academic impact, for papers by Ian M. Fowler Breakdown of academic impact, for papers by Rachel Goldgrub